Jubilant Ingrevia Profit Down 32% on Flat Sales; ₹2.50 Dividend Declared

CHEMICALS

Overview

Specialty chemicals firm Jubilant Ingrevia Ltd saw its net profit plummet 32.4% to ₹47 crore in the third quarter, facing headwinds as revenue remained flat at ₹1,051 crore. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) fell 8.5% and margins contracted. The company's board declared an interim dividend of ₹2.50 per share.

The challenging quarter for Jubilant Ingrevia was marked by a significant drop in profitability, with net profit sliding 32.4% year-on-year to ₹47 crore. This decline occurred despite revenue remaining largely stagnant, inching up by a marginal 0.5% to ₹1,051 crore in the three months ended December 31.

Financial Performance Under Pressure

EBITDA fell 8.5% to ₹126.1 crore from ₹137.9 crore in the corresponding quarter last year. The company's EBITDA margin consequently contracted to 12%, down from 13% in the prior-year period, indicating increased cost pressures or a less favorable product mix.

Dividend Payout for Shareholders

Despite the weaker financial performance, Jubilant Ingrevia's board announced an interim dividend of ₹2.50 per equity share for the financial year 2025-26. The record date for this payout is set for February 10, 2026, with payments expected by March 4, 2026. This move aims to reward shareholders amidst the current earnings pressure.

Board Appointments

In governance-related news, the board approved the re-appointment of Ameeta Chatterjee for a fresh five-year term, commencing April 17, 2026, and concluding on April 16, 2031, subject to shareholder approval. Chatterjee brings over 23 years of corporate experience in project finance and corporate finance.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.